Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.
Jørgensen CK, Juul S, Siddiqui F, Horowitz MA, Moncrieff J, Munkholm K, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Jørgensen CK, et al. Among authors: kirsch i. Syst Rev. 2023 Mar 30;12(1):57. doi: 10.1186/s13643-023-02221-5. Syst Rev. 2023. PMID: 36991504 Free PMC article.
What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol.
Pigott HE, Kim T, Xu C, Kirsch I, Amsterdam J. Pigott HE, et al. Among authors: kirsch i. BMJ Open. 2023 Jul 25;13(7):e063095. doi: 10.1136/bmjopen-2022-063095. BMJ Open. 2023. PMID: 37491091 Free PMC article.
A qualitative study of imaginary pills and open-label placebos in test anxiety.
Buergler S, Sezer D, Busch A, Enzmann M, Bakis B, Locher C, Bagge N, Kirsch I, Carvalho C, Gaab J. Buergler S, et al. Among authors: kirsch i. PLoS One. 2023 Sep 1;18(9):e0291004. doi: 10.1371/journal.pone.0291004. eCollection 2023. PLoS One. 2023. PMID: 37656757 Free PMC article. Clinical Trial.
CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy.
Silbert SK, Scanlon S, Wang HW, Yuan CM, Doverte A, Wellek J, Patel N, Braylan R, Ahlman M, Turkbey EB, Bohling SD, Chisholm KM, Oztek MA, LaLoggia M, Verma A, Shalabi H, Kovach AE, Wood BL, Lamble A, Kirsch I, Leger K, Shah NN. Silbert SK, et al. Among authors: kirsch i. J Immunother Cancer. 2024 Oct 26;12(10):e009499. doi: 10.1136/jitc-2024-009499. J Immunother Cancer. 2024. PMID: 39461880 Free PMC article.
The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.
Kamp CB, Petersen JJ, Faltermeier P, Juul S, Siddiqui F, Moncrieff J, Horowitz MA, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Kamp CB, et al. Among authors: kirsch i. Epidemiol Psychiatr Sci. 2024 Oct 23;33:e51. doi: 10.1017/S2045796024000520. Epidemiol Psychiatr Sci. 2024. PMID: 39440379 Free PMC article.
Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis.
Kamp CB, Petersen JJ, Faltermeier P, Juul S, Siddiqui F, Barbateskovic M, Kristensen AT, Moncrieff J, Horowitz MA, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Kamp CB, et al. Among authors: kirsch i. BMJ Ment Health. 2024 Jan 22;27(1):e300730. doi: 10.1136/bmjment-2023-300730. BMJ Ment Health. 2024. PMID: 39093721 Free PMC article.
432 results